138 related articles for article (PubMed ID: 18312827)
1. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)nortropane in rats.
Koivula T; Marjamäki P; Haaparanta M; Fagerholm V; Grönroos T; Lipponen T; Perhola O; Vepsäläinen J; Solin O
Nucl Med Biol; 2008 Feb; 35(2):177-83. PubMed ID: 18312827
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2beta-carbomethoxy-3beta-(4-[18F]fluorophenyl)tropane and N-(3-[18F]fluoropropyl)-2beta-carbomethoxy-3beta-(4-fluorophenyl)nortropane, tracers for imaging dopamine transporter in rat.
Marjamäki P; Haaparanta M; Forsback S; Fagerholm V; Eskola O; Grönroos T; Koivula T; Solin O
Mol Imaging Biol; 2010 Jun; 12(3):269-77. PubMed ID: 19949983
[TBL] [Abstract][Full Text] [Related]
3. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
[TBL] [Abstract][Full Text] [Related]
4. [18F]CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats.
Haaparanta M; Bergman J; Laakso A; Hietala J; Solin O
Synapse; 1996 Aug; 23(4):321-7. PubMed ID: 8855517
[TBL] [Abstract][Full Text] [Related]
5. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part I: PET studies.
Saba W; Peyronneau MA; Dollé F; Goutal S; Bottlaender M; Valette H
Nucl Med Biol; 2012 Feb; 39(2):227-33. PubMed ID: 22033025
[TBL] [Abstract][Full Text] [Related]
6. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM
Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements.
Zoghbi SS; Shetty HU; Ichise M; Fujita M; Imaizumi M; Liow JS; Shah J; Musachio JL; Pike VW; Innis RB
J Nucl Med; 2006 Mar; 47(3):520-7. PubMed ID: 16513622
[TBL] [Abstract][Full Text] [Related]
8. [18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter.
Lundkvist C; Halldin C; Ginovart N; Swahn CG; Farde L
Nucl Med Biol; 1997 Oct; 24(7):621-7. PubMed ID: 9352532
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters.
Goodman MM; Keil R; Shoup TM; Eshima D; Eshima L; Kilts C; Votaw J; Camp VM; Votaw D; Smith E; Kung MP; Malveaux E; Watts R; Huerkamp M; Wu D; Garcia E; Hoffman JM
J Nucl Med; 1997 Jan; 38(1):119-26. PubMed ID: 8998165
[TBL] [Abstract][Full Text] [Related]
11. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of novel tropane analogues in comparison with the binding characteristics of [18F]FP-CIT and [131I]beta-CIT.
Sihver W; Drewes B; Schulze A; Olsson RA; Coenen HH
Nucl Med Biol; 2007 Feb; 34(2):211-9. PubMed ID: 17307129
[TBL] [Abstract][Full Text] [Related]
13. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
Davis MR; Votaw JR; Bremner JD; Byas-Smith MG; Faber TL; Voll RJ; Hoffman JM; Grafton ST; Kilts CD; Goodman MM
J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810
[TBL] [Abstract][Full Text] [Related]
14. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
Sasaki T; Ito H; Kimura Y; Arakawa R; Takano H; Seki C; Kodaka F; Fujie S; Takahata K; Nogami T; Suzuki M; Fujiwara H; Takahashi H; Nakao R; Fukumura T; Varrone A; Halldin C; Nishikawa T; Suhara T
J Nucl Med; 2012 Jul; 53(7):1065-73. PubMed ID: 22689927
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biodistribution of [18F]FE@CIT, a new potential tracer for the dopamine transporter.
Mitterhauser M; Wadsak W; Mien LK; Hoepping A; Viernstein H; Dudczak R; Kletter K
Synapse; 2005 Feb; 55(2):73-9. PubMed ID: 15529336
[TBL] [Abstract][Full Text] [Related]
17. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.
Varrone A; Steiger C; Schou M; Takano A; Finnema SJ; Guilloteau D; Gulyás B; Halldin C
Synapse; 2009 Oct; 63(10):871-80. PubMed ID: 19562698
[TBL] [Abstract][Full Text] [Related]
18. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: Metabolism studies.
Peyronneau MA; Saba W; Dollé F; Goutal S; Coulon C; Bottlaender M; Valette H
Nucl Med Biol; 2012 Apr; 39(3):347-59. PubMed ID: 22154687
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.
Chalon S; Hall H; Saba W; Garreau L; Dollé F; Halldin C; Emond P; Bottlaender M; Deloye JB; Helfenbein J; Madelmont JC; Bodard S; Mincheva Z; Besnard JC; Guilloteau D
J Pharmacol Exp Ther; 2006 Apr; 317(1):147-52. PubMed ID: 16339913
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
Nurmi E; Bergman J; Eskola O; Solin O; Hinkka SM; Sonninen P; Rinne JO
J Cereb Blood Flow Metab; 2000 Nov; 20(11):1604-9. PubMed ID: 11083235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
